REYATAZ 150MG 60 CPS BL ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
265Lipodystrophy1

265. Lipodystrophy


Clinical trials : 116 Drugs : 170 - (DrugBank : 61) / Drug target genes : 26 - Drug target pathways : 97
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002740-10-IT
(EUCTR)
04/07/200524/01/2006A phase IV, open-label, randomized, multicenter trial assessing a reyataz-based substitution approach in the management of lipodystrophy syndrome.A phase IV, open-label, randomized, multicenter trial assessing a reyataz-based substitution approach in the management of lipodystrophy syndrome. HIV
MedDRA version: 6.1;Level: PT;Classification code 10049287
Trade Name: REYATAZ 150MG 60 CPS BL
INN or Proposed INN: atazanavir
BRISTOL-M.SQUIBBNULLNot RecruitingFemale: yes
Male: yes
300Phase 4Germany;United Kingdom;Spain;Italy